What is the elimination half-life of methamphetamine in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Half-Life of Methamphetamine in Adults

The elimination half-life of methamphetamine in adults is approximately 10-12 hours, with a reported range of 4-15 hours depending on individual variability and urine pH. 1

Pharmacokinetic Details

The FDA drug label for methamphetamine specifies a biological half-life in the range of 4 to 5 hours 1, though this represents the lower end of observed values. More comprehensive research demonstrates considerable inter-individual variability, with the mean elimination half-life being approximately 10 hours 2.

Route-Specific Half-Life Data

Multiple high-quality pharmacokinetic studies provide consistent half-life measurements across different routes of administration:

  • Intravenous administration: 11.4 hours 3, 12.2 hours 4
  • Intranasal administration: 10.7 hours 3
  • Smoked administration: 10.7 hours 3, 11.1 hours 4
  • Oral administration: 10.1 hours (range 6.4-15.1 hours) 5

The elimination half-life remains relatively consistent regardless of route of administration, typically falling between 10-12 hours 6, 3, 4.

Factors Affecting Half-Life

Urine pH Dependency

Critical clinical consideration: The half-life is highly dependent on urine pH. Alkaline urine significantly increases the drug half-life by reducing renal clearance 1. This pH-dependent elimination is clinically relevant because:

  • Approximately 62% of an oral dose is eliminated in urine within 24 hours
  • About one-third is excreted as intact drug, with the remainder as metabolites
  • Renal clearance of methamphetamine is approximately 100 mL/h/kg 3

Stereoisomer Differences

The l-methamphetamine enantiomer has a longer elimination half-life (13.3-15.0 hours) compared to d-methamphetamine (10.2-10.7 hours) 6. When racemic methamphetamine is administered, the area under the curve for d-methamphetamine is 30% smaller than for l-methamphetamine, reflecting these pharmacokinetic differences.

Active Metabolite Considerations

Methamphetamine is metabolized to amphetamine (dextroamphetamine), which has a longer half-life of approximately 16.2 hours 3. The amphetamine metabolite has a renal clearance of approximately 1100 mL/h/kg 3, contributing to prolonged stimulant effects beyond the parent compound's elimination.

Clinical Implications

Steady-State Achievement

Steady-state plasma concentrations are achieved within 4-5 half-lives, or approximately 24 hours after initiation or dose adjustment 7. This timeframe is important for:

  • Assessing therapeutic response in ADHD treatment
  • Evaluating withdrawal symptoms
  • Drug screening interpretation

Withdrawal Timeline

Based on the elimination half-life, acute withdrawal symptoms typically last 7-10 days after cessation, though residual symptoms associated with neurotoxicity may persist for several months 2.

Detection Window

Given the half-life and renal excretion patterns, methamphetamine can be detected in urine for approximately 24-48 hours in most users, though this window extends with chronic use and alkaline urine pH.

References

Research

A review of the clinical pharmacology of methamphetamine.

Addiction (Abingdon, England), 2009

Research

The bioavailability of intranasal and smoked methamphetamine.

Clinical pharmacology and therapeutics, 2003

Research

Pharmacokinetics of oral methamphetamine and effects of repeated daily dosing in humans.

Drug metabolism and disposition: the biological fate of chemicals, 1992

Research

Human pharmacology of the methamphetamine stereoisomers.

Clinical pharmacology and therapeutics, 2006

Related Questions

What is the duration of methamphetamine's psychoactive effects for each route of administration (smoked/injected versus oral)?
Will consuming two tablespoons of Santa Cruz organic crunchy peanut butter about 30 minutes before taking my immediate‑release Adderall (mixed amphetamine salts) affect the medication’s potency or absorption?
In an adult with normal gastrointestinal function, does eating a slice of sourdough bread a few minutes before taking immediate‑release Adderall (amphetamine) affect its potency or delay its onset?
Can mixed‑amphetamine salts extended‑release (Adderall XR) cause visual changes?
What is the effect of Adderall (mixed amphetamine salts) on appetite and how can appetite suppression be managed?
What are the distinguishing clinical features and recommended first-line management for fibromyalgia compared with polymyalgia rheumatica?
What are the common intravenous agents used to support blood pressure in adult intensive care unit patients?
What is the recommended management for an 80‑year‑old patient with necrotising fasciitis of the left upper limb, impaired renal function (creatinine 4 mg/dL, oliguria 350 mL/24 h), on norepinephrine (noradrenaline) infusion, receiving oxygen therapy, and moderate left‑ventricular dysfunction?
How should I manage a painful popping temporomandibular joint (TMJ)?
What are the indications for evaluating elevated prolactin levels?
What is the recommended treatment for occlusion of the mid‑right anterior tibial artery with a single distal runoff vessel?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.